CXCR4/ACKR3/CXCL12 axis in the lymphatic metastasis of vulvar squamous cell carcinoma.
Natalia RusetskaKamil KowalskiKamil ZalewskiSebastian ZiębaMariusz BidzinskiKrzysztof GorycaBeata U KotowiczMalgorzata FuksiewiczJanusz KopczynskiElwira Bakuła-ZalewskaArtur KowalikMagdalena KowalewskaPublished in: Journal of clinical pathology (2021)
It appears that during progression and lymphatic spread of VSCC, the CXCR4/ACKR3/CXCL12 axis is activated. Moreover, our data suggest that CXCR4 antagonists merit further attention as a possible therapeutic option in patients with VSCC.